Hypersensitivity to the drug components, pregnancy and lactation period, oppression of bone marrow hematopoiesis, acute intermittent porphyria, deficiency of glucose-6-phosphate dehydrogenase, hepatic, renal failure, skin diseases (fungal diseases, psoriasis, eczema), neonatal period (up to 4 weeks).